載入...
4CPS-110 Impact of patients’ conditions on the effectiveness and safety of erlotinib in pancreatic cancer
BACKGROUND: In post-PA studies in the use of erlotoinib, it was observed that the favourable clinical situation benefited the response to treatment. PURPOSE: To compare the effectiveness and safety of erlotinib, according to the Eastern Cooperative Oncology Group (ECOG), in pancreatic cancer. MATERI...
Na minha lista:
| 發表在: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Group
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535307/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.201 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|